NCT02115594View on ClinicalTrials.gov

Phase 2 Study of Fulvestrant With and Without Entinostat in Postmenopausal Women With ER+ Advanced Breast Cancer

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

June 30, 2016

Conditions
Breast Cancer
Interventions
DRUG

Fulvestrant

DRUG

Entinostat

DRUG

Placebo

Trial Locations (1)

37203

Tennessee Oncololgy, Nashville

Sponsors
All Listed Sponsors
lead

Syndax Pharmaceuticals

INDUSTRY